MedTrace Logo

Splenic Artery Ligation and Portocaval Shunt in Small-for-size Syndrome

NCT05459883 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2022-07-15

No results posted yet for this study

Summary

Our study aimed at assessing the changes of portal vein pressure, portal vein flow and hepatic arterial flow (HAF) in liver remnants ≤ 30% of the standard liver volume by reducing portal vein overflow via ligation of the splenic artery.

Conditions

  • Small-For-Size Liver Syndrome
  • Ligation
  • Liver Regeneration
  • Splenic Artery
  • Portal Vein
  • Ischemia
  • Reperfusion Injury
  • Hepatectomy

Interventions

PROCEDURE

splenic artery ligation

We identified portal hyperperfusion as a cause of potential small-for-size liver remnant dysfunction and we applied splenic artery ligation as a technically simple procedure to manage the situation

Sponsors & Collaborators

  • Aretaieion University Hospital

    lead OTHER

Principal Investigators

  • Kassiani Theodoraki · Aretaieion University Hospital, Athens, Greece

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05459883 on ClinicalTrials.gov